111 related articles for article (PubMed ID: 23967745)
1. [Effects of PPAR-alpha activation on oleic acid-induced steatosis and expression of heme oxygenase-1 in HepG2 cells].
Zhao JJ; Zhao LF; Yang H; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):218-21. PubMed ID: 23967745
[TBL] [Abstract][Full Text] [Related]
2. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.
Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A
Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006
[TBL] [Abstract][Full Text] [Related]
3. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
4. [Expression of aquaporin 3 and aquaporin 9 is regulated by oleic acid through the PI3K/Akt and p38 MAPK signaling pathways].
Gu LY; Qiu LW; Chen XF; Lv L; Mei ZC
Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):753-8. PubMed ID: 24331633
[TBL] [Abstract][Full Text] [Related]
5. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
[TBL] [Abstract][Full Text] [Related]
6. Oleic acid-induced hepatic steatosis is coupled with downregulation of aquaporin 3 and upregulation of aquaporin 9 via activation of p38 signaling.
Gu LY; Qiu LW; Chen XF; Lü L; Mei ZC
Horm Metab Res; 2015 Apr; 47(4):259-64. PubMed ID: 25105540
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
[TBL] [Abstract][Full Text] [Related]
8. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.
Ricchi M; Odoardi MR; Carulli L; Anzivino C; Ballestri S; Pinetti A; Fantoni LI; Marra F; Bertolotti M; Banni S; Lonardo A; Carulli N; Loria P
J Gastroenterol Hepatol; 2009 May; 24(5):830-40. PubMed ID: 19207680
[TBL] [Abstract][Full Text] [Related]
10. Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells.
Wu HT; Chen W; Cheng KC; Ku PM; Yeh CH; Cheng JT
J Nutr Biochem; 2012 Oct; 23(10):1264-70. PubMed ID: 22209682
[TBL] [Abstract][Full Text] [Related]
11. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
12. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.
Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG
PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a hepatocyte steatosis model using Chang liver cells.
Yan D; Dou QL; Wang Z; Wei YY
Genet Mol Res; 2015 Nov; 14(4):15224-32. PubMed ID: 26634485
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in hepatocyte steatosis model].
Zhang Q; Zhang ZX; Fang Q; Gao FY; Zhao QL; Yang Y; Su HM; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):196-200. PubMed ID: 22475139
[TBL] [Abstract][Full Text] [Related]
15. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells.
Kang OH; Kim SB; Seo YS; Joung DK; Mun SH; Choi JG; Lee YM; Kang DG; Lee HS; Kwon DY
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2578-86. PubMed ID: 24142602
[TBL] [Abstract][Full Text] [Related]
16. [Effect of polyene phosphatidyl choline on hepatocyte steatosis via PPARα/CPT-1A pathway].
Wang T; Chen DF
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):291-6. PubMed ID: 27470629
[TBL] [Abstract][Full Text] [Related]
17. [Establishment and optimization of hepatocyte steatosis model].
Gao JX; Li XJ; Zhang W; Li YS; Tang HB
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):922-926. PubMed ID: 30669785
[No Abstract] [Full Text] [Related]
18. [Comparison of effects of oleic acid and palmitic acid on lipid deposition and mTOR / S6K1 / SREBP-1c pathway in HepG2 cells].
Zhou YP; Wu R; Shen W; Yu HH; Yu SJ
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):451-456. PubMed ID: 30317760
[No Abstract] [Full Text] [Related]
19. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model.
Alwayn IP; Andersson C; Lee S; Arsenault DA; Bistrian BR; Gura KM; Nose V; Zauscher B; Moses M; Puder M
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1011-9. PubMed ID: 16844679
[TBL] [Abstract][Full Text] [Related]
20. [Study of synergistic effect of free fatty acid and iron on the establishment of nonalcoholic fatty liver disease model].
Wu Y; Ye Q; Zheng Q; Zhang L; Zhao Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Oct; 48(10):904-8. PubMed ID: 25573131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
